Sodium-glucose cotransporter 2 (SGLT-2): Cause of prolonged euglycaemic ketoacidosis and ketonaemia following general anaesthesia?

被引：0
|
作者：
Chong, Z. M. [1 ]
Stirling, A. [1 ]
Sandeep, T. [1 ]
机构：
[1] Monklands Hosp, Diabet & Endocrinol, Airdrie, Lanark, Scotland
来源：
DIABETIC MEDICINE | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P205
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [21] Prolonged euglycemic diabetic ketoacidosis triggered by a single dose of sodium-glucose cotransporter 2 inhibitor
    Miwa, Maki
    Nakajima, Mikio
    Kaszynski, Richard H.
    Goto, Hideaki
    BMJ CASE REPORTS, 2020, 13 (10)
  • [22] Sodium-glucose cotransporter 2 inhibitor-induced euglycaemic diabetic ketoacidosis in heart failure with preserved ejection fraction
    Cavka, Luka
    Bencak Ferko, Urska
    Pitz, Natasa
    Trpkovski, Zoranco
    Lainscak, Mitja
    ESC HEART FAILURE, 2021, 8 (04): : 2631 - 2636
  • [23] Forewarned is forearmed; Post operative euglycaemic ketoacidosis in a diabetic bariatric patient on Canaglifozin (a sodium-glucose cotransporter 2 inhibitor)
    Westley, Suzanne
    Sherwood, Olivia
    Margarson, Mike
    Albon, Lorraine
    Laji, Ken
    Slater, Guy
    Pring, Christopher
    Hawkins, Will
    Bosman, Deborah
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 14 - 14
  • [24] Sodium-glucose cotransporter 2 (SGLT-2) inhibition and kidney protection: Does improvement in kidney hypoxia play a role?
    Burnier, Michel
    ECLINICALMEDICINE, 2021, 37
  • [25] Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline
    Agarwal, Arnav
    Zeng, Xiaoxi
    Li, Sheyu
    Rayner, Daniel
    Foroutan, Farid
    Aertgeerts, Bert
    Coyac, Frederic
    Farhoumand, Pauline Darbellay
    Demaine, Andrew
    Heen, Anja Fog
    Jha, Vivekanand
    Machuve, Edward
    Nagler, Evi
    Tunnicliffe, David J.
    Guyatt, Gordon H.
    Vandvik, Per Olav
    Ponte, Belen
    Agoritsas, Thomas
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 387
  • [26] Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients
    Sata, Suchita Shah
    Spratt, Susan E.
    Edmonston, Daniel L.
    Pagidipati, Neha
    JOURNAL OF HOSPITAL MEDICINE, 2022, 17 (05) : 360 - 363
  • [27] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke - Reply
    Kaku, Kohei
    Lee, Jisoo
    Kaspers, Stefan
    Woerle, Hans J.
    George, Jyothis T.
    CIRCULATION JOURNAL, 2017, 81 (06) : 899 - 899
  • [28] Prolonged Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Postmarketing Cases
    Woronow, Daniel
    Chamberlain, Christine
    Houstoun, Monika
    Munoz, Monica
    ENDOCRINE PRACTICE, 2024, 30 (07) : 603 - 609
  • [29] Euglycemic Diabetic Ketoacidosis Secondary to Sodium-Glucose Cotransporter 2 Inhibitors
    Khaliq, M. F.
    Mohamed, H. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [30] Euglycemic diabetic ketoacidosis in a patient on sodium-glucose cotransporter 2 inhibitors
    Hammond, Daniel B.
    Ingram, Claire C.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (09):
12345